Advanced Solid Tumours Clinical Trials

56 clinical trials for Advanced Solid Tumours across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Understanding the Genetic and Biological Factors That Influence Cancer Treatment Response and Resistance in Patients With Advanced Solid Tumours Through Sample Analysis — RECRUITING
• A Safety and Pharmacokinetics Study of RC220 Combined With Doxorubicin in Adult Participants With Solid Tumours. — RECRUITING · PHASE1
• A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer — RECRUITING · PHASE1
• A Study of EBC-129 in Advanced Solid Tumours — RECRUITING · PHASE1
• First in Human Study of SIM0610 in Solid Tumors — RECRUITING · PHASE1
• A Study of LM-168 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid Tumours — RECRUITING · PHASE1
• A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1301 in Advanced Solid Tumors. — RECRUITING · PHASE1
• A phase 1/2 dose-escalation study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of SN38-SPL9111 (DEP®-SN38), a SN38 dendrimer conjugate, in patients with advanced solid tumours. — OTHER · PHASE2
• A Study to Evaluate the Safety and Pharmacokinetics of Ceralasertib in Combination With Durvalumab in Chinese Patients With Advanced Solid Tumours — ACTIVE_NOT_RECRUITING · PHASE1
• A PHASE 1/1B, OPEN-LABEL, MULTICENTER, FIRST-IN-HUMAN DOSE ESCALATION AND DOSE EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS, AND ANTI-TUMOR ACTIVITY OF VVD-159642 AS A SINGLE AGENT AND IN COMBINATION IN PARTICIPANTS WITH ADVANCED SOLID TUMORS — NOT_YET_RECRUITING · PHASE1
• A first-in-human, open-label, multicenter Phase I/II study to evaluate the safety and anti-tumor activity of ANV600 as single agent and in combination with pembrolizumab in participants with advanced solid tumors (EXPAND-1) — OTHER · PHASE2
• Trial to study the safety, pharmacokinetics and preliminary antitumour activity of ODM-216 in patients with cancer — NOT_YET_RECRUITING · PHASE2
• A Study to Evaluate the Effect of Ceralasertib on Drug X, Drug Y and Drug Z — TERMINATED · PHASE1
• A Study to Evaluate MEDI5752 in Subjects with Advanced Solid Tumors — TERMINATED · PHASE1
• First in Human Study of AZD9592 in Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• A Phase I/IIa Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD0022 as Monotherapy and in Combination With Anti-cancer Agents in Adult Participants With Tumours Harbouring a KRASG12D Mutation — TERMINATED · PHASE1
• Safety, Tolerability and Pharmacokinetics of AZD1775 (Adavosertib) Plus MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumours — COMPLETED · PHASE1
• A study to test how different doses of BI 1703880 in combination with ezabenlimab are tolerated in people with different types of advanced cancer (solid tumours) — TERMINATED · PHASE1
• A Phase 1 Study of [225Ac]-FPI-1434 Injection — TERMINATED · PHASE1
• A Study to Assess the Safety and Tolerability of RC88 for Patients With Advanced Solid Tumours — COMPLETED · PHASE1
• A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer — COMPLETED · PHASE2
• Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging Biomarkers — ACTIVE_NOT_RECRUITING · PHASE2
• A Study to Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2) — COMPLETED · PHASE2
• Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours — COMPLETED · PHASE1
• First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours — COMPLETED · PHASE1
• BT1718 in Patients with Advanced Solid Tumours. — COMPLETED · PHASE1
• PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclib — COMPLETED · PHASE1
• IMP4297 in Combination With Temozolomide in Patients With Advanced Solid Tumors and Small Cell Lung Cancer — COMPLETED · PHASE1
• A Phase 1 study to look at RP-6306 in combination with FOLFIRI as a treatment for Advanced Solid Tumours — OTHER · PHASE1
• AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer — COMPLETED · PHASE1
• A Study of RC88 Combined With Sintilimab for Advanced Solid Tumours — OTHER · PHASE1
• Study to Assess EXS21546 in Combination in Patients With Advanced Solid Tumours — TERMINATED · PHASE1
• A Study of PM1021 (Anti-TIGIT) With or Without PM8001 (Anti-PD-L1/TGF-β) in Patients With Advanced Solid Tumours — OTHER · PHASE1
• Study to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced Cancer — COMPLETED · PHASE1
• A Study to Assess the Effects of Itraconazole, Rifampicin, and Omeprazole on Pharmacokinetics of Adavosertib — TERMINATED · PHASE1
• A Study to Assess the Safety and Tolerability of Adavosertib for Patients With Advanced Solid Tumours — TERMINATED · PHASE1
• Capivasertib China PK Study — COMPLETED · PHASE1
• Study of Adavosertib(AZD1775) in Japanese Patients With Advanced Solid Tumours — COMPLETED · PHASE1
• A Study of SHR-A1921 for Injection in Subjects With Advanced Solid Tumours — OTHER · PHASE1
• Extended Use of ModraDoc006/r — COMPLETED · PHASE1
• Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours — OTHER · PHASE1
• A Study of IMP4297 in Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• The Safety and Pharmacokinetics of IMP4297 in Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• A Phase I Study of Safety, Tolerability, and PK of AZD2811 in Patients With Advanced Solid Tumors. — COMPLETED · PHASE1
• Phase I Dose-Escalation Study of AZD4785 in Patients With Advanced Solid Tumours — COMPLETED · PHASE1
• The Pharmacokinetics and Safety of Olaparib Alone and With Paclitaxel in Chinese Patients With Advanced Solid Tumour. — COMPLETED · PHASE1
• Phase Ib Study AZD1775 in Combination With Carboplatin and Paclitaxel in Adult Asian Patients With Solid Tumours — COMPLETED · PHASE1
• Phase I Study of AT13148, a Novel AGC Kinase Inhibitor — COMPLETED · PHASE1
• A Phase I Study of AZD0424 Alone and in Combination in Advanced Solid Tumours — TERMINATED · PHASE1
• Study of the Safety and Tolerability of PG545 in Patients With Advanced Solid Tumours — TERMINATED · PHASE1

Refine this search